Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

John Bentil

Advertisement

Articles by John Bentil

How Tax Reform Will Affect the Pharmaceutical Industry

ByJohn Bentil
February 15th 2018

Pharmaceutical Executive

This article examines the key ways the new tax bill will impact the pharmaceutical industry.

Advertisement

Latest Updated Articles

  • How Tax Reform Will Affect the Pharmaceutical Industry
    How Tax Reform Will Affect the Pharmaceutical Industry

    February 15th 2018



Advertisement
Advertisement

Trending on PharmExec

1

DTP is Scaling Fast, the Safety Infrastructure is Not

2

Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration

3

U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels

4

FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab

5

AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us